Collectively, these results indicate that the acute induction of ATF4-regulated pathways can selectively induce cell death of p30-expressing cells, and suggest that this could be exploited as a vulnerability to treat leukemia patients with N-terminal CEBPA mutations. This evidence concerns the gene ATF4 and leukemia.